Naloxone-reversible modulation of pain circuitry by left prefrontal RTMS

Neuropsychopharmacology

Volumn 38, Issue 7, 2013, Pages 1189-1197

  Taylor, Joseph J ^a   Borckardt, Jeffrey J ^a   Canterberry, Melanie ^a   Li, Xingbao ^a   Hanlon, Colleen A ^a   Brown, Truman R ^a   George, Mark S ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

analgesia; endogenous opioids; imaging; pain modulation; prefrontal cortex; rTMS

Indexed keywords

CAPSAICIN; NALOXONE;

ADULT; ALLODYNIA; ANALGESIA; ANTERIOR CINGULATE; ARTICLE; ATTENUATION; BLOOD OXYGENATION; BOLD SIGNAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG INFUSION; DRUG MECHANISM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEAT; HUMAN; HUMAN EXPERIMENT; MEDULLA OBLONGATA; MESENCEPHALON; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN ASSESSMENT; PREFRONTAL CORTEX; PRIORITY JOURNAL; THALAMUS; TIME SERIES ANALYSIS; TRANSCRANIAL MAGNETIC STIMULATION; VOXEL BASED MORPHOMETRY;

ADOLESCENT; ADULT; ANALGESIA; BRAIN; BRAIN MAPPING; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NALOXONE; NARCOTIC ANTAGONISTS; PAIN; PAIN MANAGEMENT; PAIN MEASUREMENT; PREFRONTAL CORTEX; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84878570836     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2013.13     Document Type: Article

References (50)

1. Akitsuki Y, Decety J (2009). Social context and perceived agency affects empathy for pain: an event-related fMRI investigation. Neuroimage 47: 722-734.
2. An X, Bandler R, Ongur D, Price JL (1998). Prefrontal cortical projections to longitudinal columns in the midbrain periaqueductal gray in macaque monkeys. J Comp Neurol 401: 455-479.
3. Andersen E (1986). Periaqueductal gray and cerebral cortex modulate responses of medial thalamic neurons to noxious stimulation. Brain Res 375: 30-36.
4. Bair MJ, Robinson RL, Katon W, Kroenke K (2003). Depression and pain comorbidity: a literature review. Arch Intern Med 163: 2433-2445.
5. Beam W, Borckardt JJ, Reeves ST, George MS (2009). An efficient and accurate new method for locating the F3 position for prefrontal TMS applications. Brain Stimul 2: 50-54.
6. Becerra L, Harter K, Gonzalez RG, Borsook D (2006). Functional magnetic resonance imaging measures of the effects of morphine on central nervous system circuitry in opioid-naive healthy volunteers. Anesth Analg 103: 208-216.
7. Berkowitz BA (1976). The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone. Clin Pharmacokinet 1: 219-230.
8. Bingel U, Lorenz J, Schoell E, Weiller C, Buchel C (2006). Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 120: 8-15.
9. Borckardt JJ, Nahas Z, Koola J, George MS (2006a). Estimating resting motor thresholds in transcranial magnetic stimulation research and practice: a computer simulation evaluation of best methods. J ECT 22: 169-175.
10. Borckardt JJ, Reeves ST, Beam W, Jensen MP, Gracely RH, Katz S et al (2011a). A randomized, controlled investigation of motor cortex transcranial magnetic stimulation (TMS) effects on quantitative sensory measures in healthy adults: evaluation of TMS device parameters. Clin J Pain 27: 486-494.
11. Borckardt JJ, Reeves ST, Frohman H, Madan A, Jensen MP, Patterson D et al (2011b). Fast left prefrontal rTMS acutely suppresses analgesic effects of perceived controllability on the emotional component of pain experience. Pain 152: 182-187.
12. Borckardt JJ, Reeves ST, Weinstein M, Smith AR, Shelley N, Kozel FA et al (2008). Significant analgesic effects of one session of postoperative left prefrontal cortex repetitive transcranial magnetic stimulation: a replication study. Brain Stimul 1: 122-127.
13. Borckardt JJ, Weinstein M, Reeves ST, Kozel FA, Nahas Z, Smith AR et al (2006b). Postoperative left prefrontal repetitive transcranial magnetic stimulation reduces patient-controlled analgesia use. Anesthesiology 105: 557-562.
14. Borras MC, Becerra L, Ploghaus A, Gostic JM, DaSilva A, Gonzalez RG et al (2004). fMRI measurement of CNS responses to naloxone infusion and subsequent mild noxious thermal stimuli in healthy volunteers. J Neurophysiol 91: 2723-2733.
15. Bragin EO, Yeliseeva ZV, Vasilenko GF, Meizerov EE, Chuvin BT, Durinyan RA (1984). Cortical projections to the periaqueductal grey in the cat: a retrograde horseradish peroxidase study. Neurosci Lett 51: 271-275.
16. Brett M, Jean-Luc A, Valabregue R, Poline J (2002). Region of interest analysis using an SPM toolbox 8th International Conference on Functional Mapping of the Human Brain Sendai, Japa.n.
17. Condes-Lara M, Omana Zapata I, Leon-Olea M, Sanchez-Alvarez M (1989). Dorsal raphe and nociceptive stimulations evoke convergent responses on the thalamic centralis lateralis and medial prefrontal cortex neurons. Brain Res 499: 145-152.
18. de Andrade DC, Mhalla A, Adam F, Texeira MJ, Bouhassira D (2011). Neuropharmacological basis of rTMS-induced analgesia: the role of endogenous opioids. Pain 152: 320-326.
19. deCharms RC, Maeda F, Glover GH, Ludlow D, Pauly JM, Soneji D et al (2005). Control over brain activation and pain learned by using real-time functional MRI. Proc Natl Acad Sci USA 102: 18626-18631.
20. Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, Lorenz J et al (2009). Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 63: 533-543.
21. Emptage NP, Sturm R, Robinson RL (2005). Depression and comorbid pain as predictors of disability, employment, insurance status, and health care costs. Psychiatr Serv 56: 468-474.
22. Fishman J, Roffwarg H, Hellman L (1973). Disposition of naloxone-7,8,3H in normal and narcotic-dependent men. J Pharmacol Exp Ther 187: 575-580.
23. Fuster JM (2001). The prefrontal cortex-an update: time is of the essence. Neuron 30: 319-333.
24. George MS, Aston-Jones G (2010). Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS). Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 35: 301-316.
25. Hains AB, Vu MA, Maciejewski PK, van Dyck CH, Gottron M, Arnsten AF (2009). Inhibition of protein kinase C signaling protects prefrontal cortex dendritic spines and cognition from the effects of chronic stress. Proc Natl AcadSci USA 106: 17957-17962.
26. Hammack SE, Cooper MA, Lezak KR (2012). Overlapping neurobiology of learned helplessness and conditioned defeat: implications for PTSD and mood disorders. Neuropharmacology 62: 565-575.
27. Hardy SG, Haigler HJ (1985). Prefrontal influences upon the midbrain: a possible route for pain modulation. Brain Res 339: 285-293.
28. Hutchison WD, Harfa L, Dostrovsky JO (1996). Ventrolateral orbital cortex and periaqueductal gray stimulation-induced effects on on-and off-cells in the rostral ventromedial medulla in the rat. Neuroscience 70: 391-407.
29. Jefferys DB, Volans GN (1983). An investigation of the role of the specific opioid antagonist naloxone in clinical toxicology. Hum Toxicol 2: 227-231.
30. Kober H, Barrett LF, Joseph J, Bliss-Moreau E, Lindquist K, Wager TD (2008). Functional grouping and cortical-subcortical interactions in emotion: a meta-analysis of neuroimaging studies. Neuroimage 42: 998-1031.
31. Krummenacher P, Candia V, Folkers G, Schedlowski M, Schonbachler G (2010). Prefrontal cortex modulates placebo analgesia. Pain 148: 368-374.
32. Lacadie CM, Fulbright RK, Rajeevan N, Constable RT, Papademetris X (2008). More accurate Talairach coordinates for neuroimaging using non-linear registration. Neuroimage 42: 717-725.
33. Lim LW, Temel Y, Visser-Vandewalle V, Blokland A, Steinbusch H (2009). Fos immunoreactivity in the rat forebrain induced by electrical stimulation of the dorsolateral periaqueductal gray matter. J Chem Neuroanat 38: 83-96.
34. Linnman C, Moulton EA, Barmettler G, Becerra L, Borsook D (2012). Neuroimaging of the periaqueductal gray: state of the field. Neuroimage 60: 505-522.
35. Lorenz J, Minoshima S, Casey KL (2003). Keeping pain out of mind: the role of the dorsolateral prefrontal cortex in pain modulation. Brain 126: 1079-1091.
36. McCarberg BH (2011). Pain management in primary care: strategies to mitigate opioid misuse, abuse, and diversion. Postgrad Med 123: 119-130.
37. O'Connell NE, Wand BM, Marston L, Spencer S, Desouza LH (2011). Non-invasive brain stimulation techniques for chronic pain. A report of a Cochrane systematic review and metaanalysis. Eur J Phys Rehabil Med 47: 309-326.
38. Petersen KL, Rowbotham MC (1999). A new human experimental pain model: the heat/capsaicin sensitization model. Neuroreport 10: 1511-1516.
39. Rajkowska G, Goldman-Rakic PS (1995a). Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria. Cereb Cortex 5: 307-322.
40. Rajkowska G, Goldman-Rakic PS (1995b). Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46 and relationship to the Talairach Coordinate System. Cereb Cortex 5: 323-337.
41. Robbins TW (2005). Controlling stress: how the brain protects itself from depression. Nat Neurosci 8: 261-262.
42. Standifer KM, Pasternak GW (1997). G proteins and opioid receptor-mediated signalling. Cell Signal 9: 237-248.
43. Taylor JJ, Borckardt JJ, George MS (2012). Endogenous opioids mediate left dorsolateral prefrontal cortex rTMS-induced analgesia. Pain 153: 1219-1225.
44. Tracey I, Mantyh PW (2007). The cerebral signature for pain perception and its modulation. Neuron 55: 377-391.
45. Tracey I, Ploghaus A, Gati JS, Clare S, Smith S, Menon RS et al (2002). Imaging attentional modulation of pain in the periaqueductal gray in humans. J Neurosci 22: 2748-2752.
46. Valet M, Sprenger T, Boecker H, Willoch F, Rummeny E, Conrad B et al (2004). Distraction modulates connectivity of the cingulofrontal cortex and the midbrain during pain-an fMRI analysis. Pain 109: 399-408.
47. Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ et al (2004). Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 303: 1162-1167.
48. Warner M, Chen LH, Makuc DM (2009). Increase in fatal poisonings involving opioid analgesics in the USA, 1999-2006. NCHS Data Brief 1-8.
49. Willer JC, Dehen H, Cambier J (1981). Stress-induced analgesia in humans: endogenous opioids and naloxone-reversible depression of pain reflexes. Science 212: 689-691.
50. Zambreanu L, Wise RG, Brooks JC, Iannetti GD, Tracey I (2005). A role for the brainstem in central sensitisation in humans. Evidence from functional magnetic resonance imaging. Pain 114: 397-407.